Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression

Oncotarget

Volumn 4, Issue 11, 2013, Pages 1882-1893

  Gualtieri, Alberto ^a   Andreola, Federica ^b   Sciamanna, Ilaria ^a   Sinibaldi Vallebona, Paola ^c   Serafino, Annalucia ^b   Spadafora, Corrado ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Breast cancer progression; Copy number amplification; LINE 1 retrotransposons; Reverse transcriptase; SINE retrotransposons

Indexed keywords

PROTEIN LINE 1; PROTEIN SINE B1; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER STAGING; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENETIC CODE; HISTOPATHOLOGY; MOUSE; NONHUMAN; RETROPOSON; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; FEMALE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RETROELEMENTS;

EID: 84890159577     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1188     Document Type: Article

References (62)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHug W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409: 860-921.
2. Jacquier A. The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat Rev Genet. 2009; 10: 833-844.
3. Berretta J and Morillon A. Pervasive transcription constitutes a new level of eukaryotic genome regulation. EMBO Rep. 2009; 10: 973-982.
4. Doolittle WF and Sapienza C. Selfish genes, the phenotype paradigm and genome evolution. Nature. 1980: 284: 601-603.
5. Orgel LE and Crick FH. Selfish DNA: the ultimate parasite. Nature. 1980; 284: 604-607.
6. Ohno S. So much "junk" DNA in our genome. Brookhaven Symp Biol. 1972; 23: 366-370.
7. Calin GA, Liu C, Ferracin M, Hyslop T, Spizzo R, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007; 12: 215-229.
8. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10: 704-714.
9. Kota SK and Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discov Today. 2010; 15: 733-740.
10. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM and Devine SE. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell. 2010; 141: 1253-1261.
11. Amaral PP, Dinger ME, Mercer TR, Mattick JS. The eukaryotic genome as an RNA machine. Science. 2008; 319: 1787-1789.
12. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10: 155-159.
13. Kloosterman WP, Plasterk RHA. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11: 441-450.
14. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS and Haussler D. Ultraconserved elements in the human genome. Science. 2004; 304: 1321-1325.
15. Visel A, Prabhakar S, Akiyama JA, Shoukry M, Lewis KD, Holt A, Plajzer-Frick I, Afzal V, Rubin EM, Pennacchio LA. Ultraconservation identifies a small subset of extremely constrained developmental enhancers. Nat Genet. 2008; 40: 158-160
16. Feschotte C. Transposable elements and the evolution of regulatory networks. Nat Rev Genet. 2008; 9: 397-405.
17. Goodier JL and Kazazian HH, Jr. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell. 2008; 135: 23-35.
18. Cordaux R and Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. 2009; 10: 691-703.
19. Kazazian HH, Jr. Mobile elements: drivers of genome evolution. Science. 2004; 303: 1626-1632.
20. Hancks DC and Kazazian HH, Jr. SVA retrotransposons: Evolution and genetic instability. Semin Cancer Biol. 2010; 20: 234-245.
21. Belancio VP, Roy-Engel AM, Deininger PL. All y'all need to know 'bout retroelements in cancer. Semin Cancer Biol. 2010; 20: 200-210.
22. Medstrand P and Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol. 1993; 67: 6778-6787.
23. Banerjee S and Thampan RV. Reverse transcriptase activity in bovine bone marrow: purification of a 66-kDa enzyme. Biochim Biophys Acta. 2000; 1480: 1-5.
24. Mwenda JM. Biochemical characterization of a reverse transcriptase activity associated with retroviral-like particles isolated from human placental villous tissue. Cell Mol Biol (Noisy-le-grand). 1993; 39: 317-328.
25. Packer AI, Manova K and Bachvarova RF. A discrete LINE-1 transcript in mouse blastocysts. Dev Biol. 1993; 157: 281-283.
26. Poznanski AA and Calarco PG. The expression of intracisternal A particle genes in the preimplantation mouse embryo. Dev Biol. 1991; 143: 271-281.
27. Deragon JM, Sinnett D and Labuda D. Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1. Embo J. 1990; 9: 3363-3368.
28. Friedlander A and Patarca R. Endogenous proviruses. Crit Rev Oncog. 1999; 10: 129-159.
29. Spadafora C. Endogenous reverse transcriptase: a mediator of cell proliferation and differentiation. Cytogenet Genome Res. 2004; 105: 346-350.
30. Sinibaldi-Vallebona P, Lavia P, Garaci E and Spadafora C. A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy. Genes Chromosomes Cancer. 2006; 45: 1-10.
31. Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD and Markovitz DM. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 2008; 82: 9329-9336.
32. Kurth R and Bannert N. Beneficial and detrimental effects of human endogenous retroviruses. Int J Cancer J Int Cancer. 2010; 126: 306-314.
33. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ 3rd, Lohr JG, Harris CC, Ding L, Wilson RK, Wheeler DA, Gibbs RA, Kucherlapati R, Lee C, Kharchenko PV, Park PJ, et al. Landscape of somatic retrotransposition in human cancers. Science. 2012; 337: 967-971.
34. Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlangen B, Wheelan S, Upton KR, Shukla R, Faulkner GJ, Largaespada DA and Kazazian HH, Jr. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012; 22: 2328-2338.
35. Sciamanna I, Landriscina M, Pittoggi C, Quirino M, Mearelli C, Beraldi R, Mattei E, Serafino A, Cassano A, Sinibaldi-Vallebona P, Garaci E, Barone C and Spadafora C. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene. 2005; 24: 3923-3931.
36. Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG and Spadafora C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 2007; 26: 4226-4233.
37. Mangiacasale R, Pittoggi C, Sciamanna I, Careddu A, Mattei E, Lorenzini R, Travaglini L, Landriscina M, Barone C, Nervi C, Lavia P and Spadafora C. Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation. Oncogene. 2003; 22: 2750-2761.
38. Landriscina M, Fabiano A, Altamura S, Bagalà C, Piscazzi A, Cassano A, Spadafora C, Giorgino F, Barone C and Cignarelli M. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. J Clin Endocrinol Metab. 2005; 90: 5663-5671.
39. Sinibaldi-Vallebona P, Matteucci C, Spadafora C. Retrotransposon-Encoded Reverse Transcriptase in the Genesis, Progression and Cellular Plasticity of Human Cancer. Cancers. 2011; 3: 1141-1157.
40. Ren J, Nichols C, Bird L, Chamberlain P, Weaver K, Short S, Stuart DI and Stammers DK. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol. 2001; 312: 795-805.
41. Landriscina M, Modoni S, Fabiano A, Fersini A, Barone C, Ambrosi A and Cignarelli M. Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine. Lancet Oncol. 2006; 7: 877-879.
42. Modoni S, Landriscina M, Fabiano A, Fersini A, Urbano N, ambrosi A and Cignarelli M. Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine. Cancer Biother Radiopharm. 2007; 22: 289-295.
43. Efavirenz in Treating Patients With Metastatic Prostate Cancer - ClinicalTrials.gov (2009). ClincalTrialsGov. Available: ttp://clinicaltrials.gov/ct2/show/NCT00964002?term=00964002&rank=1. Accessed 17 June 2013.
44. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton Hc, Pochanard P, Mozes E, Garraway LA and Pe'er D. An integrated approach to uncover drivers of cancer. Cell. 2010; 143: 1005-1017.
45. Guy CT, CardiffRD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992; 12: 954-961.
46. Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010; 70: 5649-5669.
47. Eroles P, Bosch A, Pérez-Fidalgo JA, Lluch A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012; 38: 698-707.
48. Clements AP and Singer MF. The human LINE-1 reverse transcriptase:effect of deletions outside the common reverse transcriptase domain. Nucleic Acids Res. 1998; 26: 3528-3535.
49. Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G and Boeke JD. Human l1 retrotransposition is associated with genetic instability in vivo. Cell. 2002; 110: 327-338.
50. Gilbert N, Lutz-Prigge S, Moran JV. Genomic deletions created upon LINE-1 retrotransposition. Cell. 2002; 110: 315-325.
51. Belgnaoui SM, Gosden RG, Semmes OJ, Haoudi A. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int. 2006; 6: 13.
52. Yang N and Kazazian HH, Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol. 2006; 13: 763-771.
53. Chen L, Dahlstrom JE, Lee S-H, Rangasamy D. Naturally occurring endo- siRNA silences LINE-1 retrotransposons in human cells through DNA methylation. Epigenetics OffJ Dna Methylation Soc. 2012; 7: 758-771.
54. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L, Barrios M, Castillejo JA, Navarro G, Colomer D, Prosper F, Heininger A and Torres A. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene. 2005; 24: 7213-7223.
55. Aporntewan C, Phokaew C, Piriyapongsa J, Ngamphiw C, Ittiwut C, Tongsima S and Mutirangura A. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. Plos One. 2011, 6: e17934.
56. Tang RB, Wang HY, Lu HY, Xiong J, Li HH, Qiu XH and Liu HQ. Increased level of polymerase III transcribed Alu RNA in hepatocellular carcinoma tissue. Mol Carcin. 2005; 42: 93-96.
57. Piskareva O, Lackington W, Lemass D, Hendrick C, Doolan P and Barron N. The human L1 element: a potential biomarker in cancer prognosis, current status and future directions. Curr Mol Med. 2011; 11: 286-303.
58. Ergün S, Buschmann C, Heukeshoven J, Dammann K, Schnieders F, Lauke H, Chalajour F, Killic N, Stratling WH and Schumann GG. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem. 2004; 279: 27753-27763.
59. Harris CR, Normart R, Yang Q, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ and Tang LH. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 2010; 1: 115-124.
60. Chen L, Dahlstrom JE, Chandra A, Board P and Rangasamy D. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res Treat. 2012; 136:129-142.
61. Vitullo P, Sciamanna I, Baiocchi M, Sinibaldi-Vallebona P, Spadafora C. LINE-1 retrotransposon copies are amplified during murine early embryo development. Mol Reprod Dev. 2012; 79: 118-127.
62. Steck E, Burkhardt M, Ehrlich H, Richter W. Discrimination between cells of murine and human origin in xenotransplants by species specific genomic in situ hybridization. Xenotransplantation. 2010; 17: 153-159.